Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Endometrial Neoplasms 6Lymphatic Metastasis 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Urologic Neoplasms 1Ureteral Neoplasms 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Postoperative Complications 1Ovarian Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Mixed Tumor, Mesodermal 1Melanoma 1Lymphedema 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease 1Cholangiocarcinoma 1

Interventions

Cisplatin 160Fluorouracil 134Paclitaxel 125Radiotherapy 117Oxaliplatin 87Carboplatin 71Docetaxel 70Irinotecan 59pembrolizumab 57Capecitabine 57Leucovorin 56Radiation 47Surgical Procedures, Operative 33Drug Therapy 33Esophagectomy 31Cetuximab 25Neoadjuvant Therapy 24Nivolumab 23Bevacizumab 21Trastuzumab 20camrelizumab 19S 1 (combination) 19Chemoradiotherapy 17Albumin-Bound Paclitaxel 16Magnetic Resonance Spectroscopy 15Epirubicin 15tislelizumab 14Taxes 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Esophageal Neoplasms × Lymph Node Excision × Clear all
NCT07519486 2026-04-15

INS-ESCC-CT

Sichuan University

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01807936 2023-07-20

Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)

Fudan University

Phase NA Completed
400 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡